BIO — Biome Australia Share Price
Last trade - 00:00- AU$97.54m
- AU$96.18m
- AU$13.07m
- 77
- 14
- 42
- 43
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 31.25 | ||
| PEG Ratio (f) | 0.33 | ||
| EPS Growth (f) | 1,627.91% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 21.52 | ||
| Price to Tang. Book | 22.18 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 6.12 | ||
| EV to EBITDA | 138.74 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.12% | ||
| Return on Equity | 8.64% | ||
| Operating Margin | 1.81% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 0.97 | 2.62 | 4.39 | 7.63 | 13.07 | 18.95 | 26.56 | 102.11% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +466.67 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Biome Australia Ltd is an Australia-based microbiome health company. The Company develops, licenses, commercializes and markets evidence-based live biotherapeutics (probiotics) and complementary medicines. It develops, manufactures, and distributes evidence-based products linking the gut and human health through the Company owned brands, such as Activated Nutrients and Activated Probiotics. Activated Nutrients offers a range of completely organic, plant-based, all in-one nutritional products. Activated Probiotics offers a range of clinically backed precision probiotics. Activated Probiotics provides live biotherapeutic products clinically proven to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema through randomized double-blind placebo-controlled trials. Activated Probiotics products include Biome Acne Probiotic, Biome Baby Probiotic, Biome Eczema Probiotic, and Biome Acne Probiotic.
Directors
- Ilario Faenza NEC
- Michael Sven Ola Oredsson CEO
- Blair William Brabin Norfolk FDR
- Chee Yong Loh CFO
- Jaroslav Boublik CSO
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 6th, 2018
- Public Since
- November 30th, 2021
- No. of Shareholders
- 2,319
- No. of Employees
- 30
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 219,197,305
- Address
- 192-194 Johnston Street, Collingwood, MELBOURNE, 3066
- Web
- https://biomeaustralia.com/
- Phone
- +61 390175800
- Auditors
- MVAB Assurance
Upcoming Events for BIO
Similar to BIO
Acrux
Australian Stock Exchange - SEATS
AFT Pharmaceuticals
Australian Stock Exchange - SEATS
Althea group
Australian Stock Exchange - SEATS
Anatara Lifesciences
Australian Stock Exchange - SEATS
Argent BioPharma
Australian Stock Exchange - SEATS
FAQ
As of Today at 19:36 UTC, shares in Biome Australia are trading at AU$0.45. This share price information is delayed by 15 minutes.
Shares in Biome Australia last closed at AU$0.45 and the price had moved by +15.58% over the past 365 days. In terms of relative price strength the Biome Australia share price has outperformed the ASX All Ordinaries Index by +13.81% over the past year.
The overall consensus recommendation for Biome Australia is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreBiome Australia does not currently pay a dividend.
Biome Australia does not currently pay a dividend.
Biome Australia does not currently pay a dividend.
To buy shares in Biome Australia you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.45, shares in Biome Australia had a market capitalisation of AU$97.54m.
Here are the trading details for Biome Australia:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: BIO
Based on an overall assessment of its quality, value and momentum Biome Australia is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Biome Australia is AU$0.85. That is 91.01% above the last closing price of AU$0.45.
Analysts covering Biome Australia currently have a consensus Earnings Per Share (EPS) forecast of AU$0.00 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biome Australia. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -35.5%.
As of the last closing price of AU$0.45, shares in Biome Australia were trading -25.63% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Biome Australia PE ratio based on its reported earnings over the past 12 months is 31.25. The shares last closed at AU$0.45.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Biome Australia's management team is headed by:
- Ilario Faenza - NEC
- Michael Sven Ola Oredsson - CEO
- Blair William Brabin Norfolk - FDR
- Chee Yong Loh - CFO
- Jaroslav Boublik - CSO